Development of resistance to beta-lactam antibiotics during therapy of Pseudomonas aeruginosa infections (Q54516017)

30 May 2018

title

Development of resistance to beta-lactam antibiotics during therapy of Pseudomonas aeruginosa infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6123740

9 August 2023

main subject

Pseudomonas aeruginosa

0 references

author name string

K. Shannon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6123740

9 August 2023

A. King

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6123740

9 August 2023

I. Phillips

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6123740

9 August 2023

language of work or name

English

0 references

publication date

1 June 1982

1 reference

30 May 2018

26 June 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6123740

full work available at URL

9 August 2023

https://api.elsevier.com/content/article/PII:S0140673682924734?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92473-4

https://api.elsevier.com/content/article/PII:S0140673682924734?httpAccept=text/plain

9 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92473-4

9 August 2023

1 reference

30 May 2018

volume

1

1 reference

30 May 2018

issue

8287

1 reference

30 May 2018

page(s)

1466

1 reference

30 May 2018

Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992473-4

7 January 2021

Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992473-4

7 January 2021

Carbenicillin Resistance in Pseudomonas aeruginosa from Clinical Material

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992473-4

7 January 2021

Clinical and pharmacological studies of ticarcillin in gram-negative infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992473-4

7 January 2021

Susceptibility patterns of bacteria following therapy with piperacillin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992473-4

7 January 2021

Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992473-4

7 January 2021

In vitro antibacterial activity and susceptibility of cefsulodin, an antipseudomonal cephalosporin, to beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992473-4

7 January 2021

Comparison of the β-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992473-4

7 January 2021

Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2992473-4

7 January 2021

The beta-lactamases of gram-negative bacteria and their possible physiological role.

6

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)92473-4

9 August 2023

Identifiers

1 reference

30 May 2018

1 reference

30 May 2018